Showing results (221-230 of 378) with videos related to
Sort By:
Pageof 38
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2010
2009 H1N1 influenza A and pregnancy outcomes in Victoria, AustraliaSaliya Hewagama, Sue P Walker, Rhonda L Stuart, et al.The Medical Journal of Australia|April 8, 2011
Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infectionAllen C Cheng, John K Ferguson, Michael J Richards, et al.F1000Research|December 23, 2020
Methods used to meta-analyse results from interrupted time series studies: A methodological systematic review protocolElizabeth Korevaar, Amalia Karahalios, Andrew B Forbes, et al.ANZ Journal of Surgery|January 9, 2021
Prevalence of asymptomatic SARS-CoV-2 infection in elective surgical patients in Australia: a prospective surveillance studyNicholas Coatsworth, Paul S Myles, Graham J Mann, et al.The American Journal of Tropical Medicine and Hygiene|October 7, 2011
Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literatureCatherine S Marshall, Allen C Cheng, Peter G Markey, et al.Archives of Internal Medicine|September 25, 2003
Clinical identifiers of complicated Staphylococcus aureus bacteremiaVance G Fowler, Maren K Olsen, G Ralph Corey, et al.AIDS (London, England)|May 31, 2018
Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individualsEmily L Woolnough, Jennifer F Hoy, Allen C Cheng, et al.Annals of Surgery|March 9, 2022
Biomarkers for the Early Diagnosis of Sepsis in Burns: Systematic Review and Meta-analysisAndrew T Li, Anthony Moussa, Eduardo Gus, et al.Journal of Clinical Microbiology|October 7, 2005
Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomalleiSharon J Peacock, Grace Chieng, Allen C Cheng, et al.Clinical & Translational Immunology|May 20, 2016
OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancerRyan Montler, R Bryan Bell, Colin Thalhofer, et al.Pageof 38